Core Viewpoint - The retail sector is experiencing a structural rally, with significant capital inflow and a shift in investment logic towards quality and service-driven growth, influenced by policy direction, corporate transformation, and upgrading consumer demand [1][2]. Group 1: Policy Direction - The Ministry of Commerce has identified the retail industry as a key focus for fostering a complete domestic demand system and strengthening the domestic circulation, emphasizing a shift towards quality and service-driven transformation [1]. - Policies encourage market penetration and the integration of online and offline development, providing a clear growth path for retail enterprises capable of transformation [1]. Group 2: Corporate Transformation - Leading retailers like Yonghui Supermarket are accelerating their "product-centered" strategy, with significant improvements in store renovations and supply chain optimization, resulting in positive same-store sales growth [2]. - Yonghui has completed renovations of 222 stores by September 2025, with new "quality retail" stores expanding its network [2]. - The traditional retail model has faced challenges due to high competition and low profitability, but Yonghui's shift to a selective retail model positions it for long-term growth in the post-consumption era [2]. Group 3: Consumer Demand Upgrade - Consumer preferences are shifting from price sensitivity to a focus on quality, experience, and emotional value, with sectors like gold jewelry and cosmetics showing strong performance [2]. - Retail sales of gold and silver jewelry increased by 37.6% year-on-year in October, with brands like Lao Pu Gold and Chao Hong Ji achieving high growth through differentiated product offerings [2]. - In the cosmetics sector, companies such as Proya and Mao Ge Ping have excelled through ingredient innovation and brand upgrades, particularly during major sales events [2]. Group 4: Investment Opportunities - Investment strategies should focus on four core themes within the retail sector: 1. Brands with differentiated product offerings and consumer insights in the gold jewelry sector, including Chao Hong Ji, Lao Pu Gold, Chow Tai Fook, and Chow Sang Sang [3]. 2. Offline retail enterprises and AI-enabled cross-border e-commerce leaders, with recommendations for Yonghui Supermarket, Ai Ying Shi, Ji Hong Co., and Sai Wei Times [3]. 3. Cyclical sectors poised for recovery, benefiting companies like Mixue Group, Gu Ming, Cha Bai Dao, Haidilao, Yum China, Jin Jiang Hotels, Shou Lv Hotels, Jun Ting Hotels, Keri International, Xiang Yuan Cultural Tourism, and Zhongxin Tourism [3]. 4. Domestic brands focusing on safe ingredient innovation and chain medical beauty institutions, including Ai Mei Ke, Mao Ge Ping, Proya, Shang Mei Co., Juzi Biology, Marubi, Runben Co., Ruo Yu Chen, and Shanghai Jahwa [3][4].

Investment Rating - Industry investment rating: Buy [3] Core Viewpoints - In November 2025, the year-on-year growth of social retail sales was 1.3%, with total retail sales amounting to 4.4 trillion CNY. This represents a decrease of 1.6 percentage points compared to October 2025. Excluding automobiles, the total retail sales reached 3.9 trillion CNY, growing by 2.5% year-on-year [6] - The report emphasizes the importance of the domestic demand expansion strategy and suggests that the retail sector is expected to enter a profit recovery phase as adjustments in supermarkets progress [6] - The report highlights the performance of various categories, noting that food and beverage retail sales grew by 6.1% and 2.9% respectively, while jewelry sales saw a significant increase of 8.5% [6] Summary by Sections Retail Sales Performance - November 2025 saw a total retail sales of 4.4 trillion CNY, with a year-on-year growth of 1.3%. The growth rate decreased by 1.6 percentage points from October 2025. Urban retail sales were 3.8 trillion CNY (1.0% growth), while rural retail sales were 0.6 trillion CNY (2.8% growth) [6] - The breakdown of retail sales shows that commodity retail was 3.8 trillion CNY (1.0% growth), and dining revenue was 0.6 trillion CNY (3.2% growth) [6] Category Performance - In November, the retail sales growth rates for staple food and beverages were 6.1% and 2.9%, respectively. However, tobacco and alcohol sales declined by 3.4% [6] - Optional consumer goods such as cosmetics and jewelry saw growth rates of 6.1% and 8.5%, while building materials, furniture, and home appliances experienced declines of 17.0%, 3.8%, and 19.4% respectively [6] E-commerce Insights - The e-commerce penetration rate slightly decreased, with online retail sales of physical goods reaching 14.5 trillion CNY, a year-on-year growth of 9.1%. The penetration rate was 25.9%, showing a 0.7 percentage point increase from the previous month but a 0.8 percentage point decrease year-on-year [6] Investment Recommendations - Retail: Focus on companies like Bubu Gao, Huijia Times, Yonghui Supermarket, and Chongqing Department Store as the industry is expected to enter a profit recovery phase [6] - Cosmetics: The report recommends companies such as Shumei Co., Mao Ge Ping, and Shui Yang Co. due to their strong performance and market positioning [6] - Jewelry: Companies with a high proportion of fixed-price products and a high-end branding strategy are highlighted, such as Laopuyin and Mankalon [6] - Tourism: Recommendations include Changbai Mountain and companies with acquisition expectations like Xiyu Tourism [6] - Education: Focus on undervalued vocational education stocks like China Oriental Education and Action Education, as well as leading companies like Xueda Education [6]

[Table_Title] 如何看 2025 年 11 月消费数据？ 联合研究丨行业点评 %% %% %% %% research.95579.com 1 丨证券研究报告丨 报告要点 [Table_Summary] 11 月份，社会消费品零售总额 43898 亿元，同比增长 1.3%。其中，除汽车以外的消费品零售 额 39444 亿元，增长 2.5%。1—11 月份，社会消费品零售总额 456067 亿元，增长 4.0%。其 中，除汽车以外的消费品零售额 411637 亿元，增长 4.6%。 分析师及联系人 [Table_Author] 李锦 赵刚 高伊楠 SAC：S0490514080004 SAC：S0490517020001 SAC：S0490517060001 SFC：BUV258 SFC：BUX176 SFC：BUW101 于旭辉 蔡方羿 董思远 SAC：S0490518020002 SAC：S0490516060001 SAC：S0490517070016 SFC：BUU942 SFC：BUV463 SFC：BQK487 陈亮 SAC：S0490517070017 SFC：BUW408 请阅读最后 ...

Core Viewpoint - Lin Qingxuan is set to go public on the Hong Kong stock market after successfully submitting its prospectus following the listing hearing, aiming to become the first high-end domestic skincare stock and the first domestic essence oil stock in China [2][17]. Financial Performance - Lin Qingxuan's revenue has significantly increased from 691.5 million RMB in 2022 to 1.209641 billion RMB in 2024, with a notable 98.3% year-on-year growth in the first half of 2025, marking its first half-year revenue exceeding 1 billion RMB [3][18]. - The company turned a profit in 2023 with a net profit of 85 million RMB, which further increased to 187 million RMB in 2024, and reached 182 million RMB in the first half of 2025, with net profit margins improving to 10.5%, 15.4%, and 17.3% respectively [4][19]. Product Structure - The core product category for Lin Qingxuan is essence oil, generating revenues of 448 million RMB in 2024 and 478 million RMB in the first half of 2025, accounting for 37% and 45.5% of total revenue respectively [5][20]. - Lin Qingxuan's camellia oil essence has ranked first in retail sales among all facial essence oil products in China for 11 consecutive years since 2014, with cumulative sales exceeding 45 million bottles by June 30, 2025 [7][22]. Sales Channels - Online sales have seen a substantial increase, with revenue rising from 312 million RMB in 2022 to 714 million RMB in 2024, achieving a compound annual growth rate of 51.2%. By the first half of 2025, online revenue reached 688 million RMB, making up 65.4% of total sales [8][23]. - Offline revenue also grew from 378 million RMB in 2022 to 494 million RMB in 2024, with a compound annual growth rate of 14.3%. As of June 30, 2025, Lin Qingxuan operated 554 stores, primarily located in shopping malls [10][25]. Market Position - Lin Qingxuan is positioned as the leading high-end domestic skincare brand in China by retail sales in 2024, and it is part of a broader trend of domestic beauty brands seeking to list in Hong Kong to enhance their capital structure and global competitiveness [11][26]. - The company is among several domestic beauty brands, including Pechoin and Marubi, that have initiated their listing processes in Hong Kong, reflecting a new phase of capitalized development in the industry [14][29].

2025 年 12 月 15 日 投资评级：看好（维持） 商贸零售 行业走势图 《医美化妆品 11 月月报：美丽田园收 购思妍丽 100%股权，双十一大促落幕 美 妆 表 现 亮 眼 — 行 业 点 评 报 告 》 -2025.12.3 11 月社零同比+1.3%，整体增速有所承压 ——行业点评报告 | 黄泽鹏（分析师） | 李昕恬（联系人） | | --- | --- | | huangzepeng@kysec.cn | lixintian@kysec.cn | | 证书编号：S0790519110001 | 证书编号：S0790125100021 | 数据来源：聚源 -36% -24% -12% 0% 12% 24% 2024-12 2025-04 2025-08 商贸零售 沪深300 相关研究报告 《商务部明确零售品质转型，关注永 辉超市调改成效 — 行 业 周 报 》 -2025.12.14 《林清轩更新招股书，关注高端国货 护 肤 公 司 上 市 进 展 — 行 业 周 报 》 -2025.12.7 lixintian@kysec.cn 证书编号：S0790125100021 2025 年 11 月 ...

Core Viewpoint - The Chinese beauty brand Marubi Biotechnology (丸美生物) is preparing for a Hong Kong IPO after experiencing a modest stock performance in A-shares, with a year-to-date increase of only 5.3% compared to significant gains by its Hong Kong counterparts [2][3]. Group 1: Company Overview - Marubi Biotechnology was founded in April 2002 and went public on the Shanghai Stock Exchange in July 2019 [3]. - The company focuses on synthetic biology technology and has developed skincare products with anti-wrinkle, firming, and repairing effects, particularly through its core technology of recombinant collagen [3]. - Marubi operates two main brands: Marubi, which specializes in eye and facial care solutions, and Lianhuo, a cost-effective makeup brand focusing on base makeup products [3]. Group 2: Financial Performance - Marubi's revenue from 2022 to 2024 was reported as 1.732 billion RMB, 2.226 billion RMB, and 2.970 billion RMB, with a compound annual growth rate (CAGR) of 31.0% [6]. - The net profit for the same period was 167 million RMB, 278 million RMB, and 342 million RMB, achieving a CAGR of 43.0% [6]. - However, net profit growth has slowed significantly, with a year-on-year increase of only 2.9% in the first nine months of the current year [6]. Group 3: Sales Channels - Marubi's sales channels include both online and offline, with online direct sales through platforms like Douyin, Tmall, and JD.com, and offline sales through distributors to specialty stores, department store counters, and beauty salons [5]. - The proportion of revenue from online direct sales has increased from 46.4% in 2022 to 74.8% in the first nine months of 2025, indicating a strong shift towards online sales [7]. Group 4: Dividend Policy and Controversy - Marubi has faced controversy over its substantial dividend payouts, which totaled 76.2 million RMB, 100 million RMB, 309 million RMB, and 301 million RMB from 2022 to 2025 [12]. - The company's significant dividends have raised questions among investors, especially in light of declining net profit growth and the potential impact on cash reserves [11][12]. - The major shareholders, Sun Huaqing and Wang Xiaopu, hold approximately 80.8% of the company, leading to concerns about the alignment of interests between the company and its investors [12]. Group 5: Future Plans - Marubi plans to use the funds raised from its IPO for enhancing its online and offline consumer engagement capabilities, marketing activities, and expanding its R&D team [13]. - The company aims to improve its supply chain capabilities and general working capital through the proceeds from the IPO [13].

从规模上看，自然堂无疑是资本市场的又一遗珠。 据招股书披露，按照零售额计算，2024 年国产化妆品集团份额 TOP3 分别为珀莱雅、上美股份、以及自然堂，市占率分别为 3.3%、1.9%、以及 1.7%。 文：向善财经 近期，国产化妆品品牌自然堂，正式向港交所递表。 对此不少网友表示心情十分激动，又一个消费大白马要来了，毕竟从财务视角看，这还是一家收入超40亿，毛利率将近70%的企业。 只不过，尽管自然堂的实力非常能打，但遗憾的是外部环境恐生变化。 一方面因为近期赴港上市的公司赚钱效应急剧下滑，首日破发的公司越来越多。据统计，11月以来上市的19只港股新股中，8只首日破发，破发率接近半 数。 比如尚未稳定盈利的小马智行-W与文远知行-W，同日上市双双破发，下跌幅度都接近10%。 对此，港交所则公开表示，政策会收紧，将严格审慎地面对诸多已经递表的企业。 另一方面，从利润端的披露情况来看，虽然占据了一定的市场份额，但是其净利率最低的一年仅仅只有3.2%，最高的一年也不到10%，这和传统认知中，大 白马动辄20%左右的净利率相差甚远，和行业龙头相比也仍有差距。 而且，从此次上市募资的用途来看，与当下的行业趋势似乎也 ...

Core Insights - The report emphasizes two main investment directions for 2026: recovery sectors focusing on profit inflection points and growth sectors targeting high revenue increases [4][19][20] Recovery Sectors - The duty-free sector is showing signs of recovery with favorable policies enhancing consumption, including expanded product categories and improved shopping convenience [4][19] - The hotel industry is expected to see a gradual improvement in RevPAR, with business and leisure demand stabilizing, indicating a potential operational turning point in Q4 or next year [4][19] - The tourism sector remains resilient despite macroeconomic pressures, with increasing travel volumes and government initiatives aimed at boosting consumption in various travel themes [4][19] Growth Sectors - The beauty industry is experiencing intensified competition, with a focus on channel value reconstruction and brand establishment [4][20] - The gold and jewelry sector is witnessing a recovery, driven by new product launches and an increasing focus on high-end market competition [4][20] - The cross-border e-commerce sector is expected to rebound, supported by stable policies and a decrease in shipping costs, with strong demand from the U.S. market [4][20] Key Company Recommendations - For duty-free, China Duty Free Group is recommended for its long-term growth potential, with attention to Wangfujing and Zhuhai Duty Free Group [4] - In the hotel sector, companies like Jinjiang Hotels, Atour, and Huazhu are highlighted for their growth prospects [4] - In tourism, companies such as Three Gorges Tourism and Changbai Mountain are suggested for monitoring acquisition and new business developments [4] - The beauty sector includes recommendations for brands like Maogeping and Proya, focusing on channel strategies [4] - For gold and jewelry, companies like Chow Tai Fook and Lao Pu Gold are recommended for their market positioning [4] - In retail, companies like Yonghui Supermarket and Xinhua Department Store are noted for their recovery potential [4]

Investment Rating - The report indicates a weak performance in the cosmetics and medical beauty sector, with the Shenwan Beauty Care Index declining by 1.6% from December 5 to December 12, 2025, underperforming the market [3][4]. Core Insights - The cosmetics sector faced pressure in November, with overall GMV in the Taobao system showing weakness due to the pre-promotion of the Double 11 sales event and the rise of Douyin as a sales channel. Brands like Han Shu and Lin Qingxuan maintained stable GMV, while others like Feicui continued to grow significantly [3][9]. - The collagen medical beauty segment is expanding, with two new animal-derived collagen products approved for market entry, expected to drive growth in this area [3][9]. - The report highlights the leading market share of Minoxidil products from Mandi International in the hair loss treatment market, with a steady revenue growth from 982 million yuan in 2022 to approximately 1.455 billion yuan in 2024, reflecting a CAGR of 21.7% from 2022 to 2024 [10][11]. - L'Oréal's acquisition of an additional 10% stake in Galderma, raising its total ownership to 20%, signifies a strategic shift towards the medical beauty and skin health sectors, aiming to adapt to the slowing growth in the Chinese beauty market [3][18]. Summary by Sections Industry Performance - The Shenwan Beauty Care Index and its sub-indices for cosmetics and personal care products have shown declines of 1.2% and 1.7%, respectively, indicating underperformance compared to the Shenwan A Index [4][6]. Key Market Developments - The overall GMV for cosmetics in November was weak, influenced by earlier sales spikes in October and competition from Douyin [9]. - The approval of new collagen products is expected to enhance the supply side of the medical beauty market, with projections for continued expansion in 2026 [9][22]. Company Highlights - Mandi International has maintained a dominant position in the Minoxidil market, with its products accounting for approximately 57% and 71% of the market share in the hair loss treatment and Minoxidil categories, respectively, as of 2024 [11][13]. - The report notes that the Chinese consumer healthcare market is projected to grow from 931.3 billion yuan in 2018 to 16.42 trillion yuan by 2024, with significant growth in hair health and skin health segments [12][13].

Investment Rating - The report maintains a "Positive" outlook on the cosmetics and medical beauty industry, despite recent underperformance compared to the market [3][4]. Core Insights - The cosmetics and medical beauty sector has shown weaker performance, with the Shenwan Beauty Care Index declining by 1.6% from December 5 to December 12, 2025, underperforming the market [4][5]. - The report highlights that the November sales in the cosmetics sector were impacted by pre-Double 11 promotions and the rise of Douyin as a sales channel, leading to a weaker overall GMV [4][10]. - The collagen medical beauty segment is expanding, with two new animal-sourced collagen products approved for market, indicating growth potential in this area [4][10]. - The report emphasizes the strong market position of Mandi International in the minoxidil hair growth market, with a revenue increase from 982 million yuan in 2022 to approximately 1.455 billion yuan in 2024, reflecting a CAGR of 21.7% [4][11][12]. - L'Oréal's recent acquisition of an additional 10% stake in Galderma signifies a strategic shift towards medical aesthetics and skin health, aiming to adapt to the slowing growth in the Chinese beauty market [4][21]. Summary by Sections Industry Performance - The Shenwan Beauty Care Index decreased by 1.6%, with the Shenwan Cosmetics Index down by 1.2% and the Shenwan Personal Care Index down by 1.7% during the specified period [4][5]. - Notable stock performances included Water Sheep Co. (+5.9%) and Jinsong New Materials (+4.3%), while Hongmian Co. (-10.6%) and Juzhi Biological (-8.4%) faced significant declines [7]. Market Trends - The overall GMV for cosmetics in November was weak, influenced by the earlier sales surge in October and the emergence of Douyin as a competitive sales platform [4][10]. - The report notes that brands like Han Shu and Lin Qingxuan maintained stable GMV, while brands like Feicui continued to experience high growth [4][10]. Company Highlights - Mandi International has established a leading position in the minoxidil market, with a market share of approximately 57% in the hair loss treatment sector and 71% in the minoxidil product market as of 2024 [4][15]. - The company has shown consistent revenue growth, with a net profit increase from 2022 to the first half of 2025, indicating a robust business model [4][12][15]. Investment Recommendations - The report recommends focusing on companies with strong product lines and high profitability in the medical beauty sector, such as Ai Meike, while also suggesting attention to companies like Langzi Co. and Ru Yi Chen [4][10].